Nepicastat Hydrochloride

N/A

Report date: 2023/03/03 20:00:36
NME

Base Information

Drug NameNepicastat Hydrochloride
Drug Alias NameDβH inhibitor programme盐酸奈匹司他nepicastatum盐酸奈卡司他奈卡司他盐酸盐 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine beta-hydroxylase inhibitors
TargetsDopamine beta-hydroxylase
Therapy Area/IndicationsStress Disorders, Post-TraumaticCocaine-Related DisordersColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiotie
China Registration ClassN/A

Develop Information

Active CompaniesAsieris Pharmaceuticals Ltd
Inactive CompaniesTuscaloosa Research And Education Advancement CorpNational Institute On Drug AbuseBiotie Therapies Inc
Active IndicationsColitis, Ulcerative
Inactive IndicationsStress Disorders, Post-TraumaticCocaine-Related Disorders

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG